Patel Gautam — SEC Form 4 filings

SEC reporting owner CIK 1738054. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-05-06 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Amneal Pharmaceuticals, Inc. (AMRX)Director139 legs · 480,000 sh · $3,951,02710
Spectrum Brands Holdings, Inc. (SPB)Director22

Form 4 filings — Patel Gautam

FiledFormIssuerReported transactionsSource
2026-08-124Amneal Pharmaceuticals, Inc. (AMRX)Grant/award (A): 283,632EDGAR
2026-05-084Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 34,819 · Option exercise (M): 34,819 (derivative) @ $0 · Grant/award (A): 19,824 (derivative) @ $0EDGAR
2025-12-164Spectrum Brands Holdings, Inc. (SPB)Grant/award (A): 4,602 @ $0EDGAR
2025-06-184Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 94,906 @ $8.02EDGAR
2025-06-124Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 56,426 @ $8.02EDGAR
2025-05-084Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 40,258 · Option exercise (M): 40,258 (derivative) @ $0 · Grant/award (A): 34,819 (derivative) @ $0EDGAR
2025-05-064Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 3,768 @ $8 · Sale (S): 4,900 @ $8EDGAR
2025-04-024Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 80,000 @ $8.30EDGAR
2025-03-054Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 80,000 @ $8.90EDGAR
2025-02-054Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 80,000 @ $8.14EDGAR
2025-01-104Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 62,590 @ $8.01EDGAR
2025-01-064Amneal Pharmaceuticals, Inc. (AMRX)Sale (S): 17,410 @ $8.01EDGAR
2024-11-204Spectrum Brands Holdings, Inc. (SPB)Grant/award (A): 2,770 @ $90.26EDGAR
2024-05-144Amneal Pharmaceuticals, Inc. (AMRX)Option exercise (M): 76,453 · Option exercise (M): 76,453 (derivative) @ $0EDGAR
2024-05-064Amneal Pharmaceuticals, Inc. (AMRX)Grant/award (A): 40,258 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1738054 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →